Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_provenance.
- NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_assertion description "[Recent advances in transgenic and gene therapy techniques have presented novel therapeutic strategies for management of heart failure via genetic manipulation of beta-AR signaling including the targeted inhibition of the beta-AR kinase (betaARK1 or GRK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_provenance.
- NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_assertion evidence source_evidence_literature NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_provenance.
- NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_assertion SIO_000772 15524162 NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_provenance.
- NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_assertion wasDerivedFrom befree-20140225 NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_provenance.
- NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_assertion wasGeneratedBy ECO_0000203 NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_provenance.
- befree-20140225 importedOn "2014-02-25" NP648525.RAkM3ll1HgWA1UE1ITFSmIiHcEkFmhHSM0eKDZFGlE9Co130_provenance.